Chemoinformaics analysis of Ellagic acid acetyl xyloside
| Molecular Weight | 476.346 | nRot | 3 |
| Heavy Atom Molecular Weight | 460.218 | nRig | 28 |
| Exact Molecular Weight | 476.059 | nRing | 5 |
| Solubility: LogS | -4.34 | nHRing | 3 |
| Solubility: LogP | -0.283 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 13 | No. of Arom Bond | 19 |
| nHA | 13 | APOL | 56.1647 |
| nHD | 5 | BPOL | 27.3353 |
| QED | 0.114 |
| Synth | 4.328 |
| Natural Product Likeliness | 1.957 |
| NR-PPAR-gamma | 0.822 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.995 |
| HIA | 0.902 |
| CACO-2 | -6.223 |
| MDCK | 0.0000361 |
| BBB | 0.017 |
| PPB | 0.723485 |
| VDSS | 0.998 |
| FU | 0.248626 |
| CYP1A2-inh | 0.05 |
| CYP1A2-sub | 0.101 |
| CYP2c19-inh | 0.011 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.026 |
| CYP2c9-sub | 0.15 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.128 |
| CYP3a4-inh | 0.036 |
| CYP3a4-sub | 0.014 |
| CL | 1.27 |
| T12 | 0.824 |
| hERG | 0.01 |
| Ames | 0.192 |
| ROA | 0.04 |
| SkinSen | 0.308 |
| Carcinogencity | 0.191 |
| EI | 0.033 |
| Respiratory | 0.014 |
| NR-Aromatase | 0.653 |
| Antiviral | Yes |
| Prediction | 0.691577 |